Patent · US Active

Synthetic gene construct coding for an HIV1 GAG and use thereof for obtaining anti-HIV-1 vaccines

US8932599B2 · kind B2 · utility

0Cited by
0References
11Claims
0Family size

Assignees

Inventors

Key dates

Filing dateSep 10, 2009
Grant dateJan 13, 2015
Priority date
Expiry dateApr 24, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2740/16122
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to a synthetic gene coding for the Gag protein of the human immunodeficiency virus HIV-1. Said gene may optionally be fused with one or more other HIV sequences. The invention may notably be used within the scope of obtaining anti-HIV vaccines.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.